The Dow Jones index and the S&P 500 rise, aided by tech stock. Novo stock soared on FDA approval for a weight-loss pill.

Oracle faces investor angst ahead of earnings as OpenAI exposure, rising capex and debt reliance weigh on shares despite massive AI-driven backlog growth.

The reaction from financial analysts was swift. Wedbush Securities raised its price target for Alphabet shares to $350, reaffirming its "Outperform" rating. Similarly, the Royal Bank of Canada ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Thomas J. Brock is a CFA and CPA with more than 20 ...

JP Morgan led the euro Reverse Yankee league table for 2025, having helped place an apportioned €10.7bn for a 12.7% market share. Last year, the US firm achieved a 12.9% market share off the back of ...